Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions
New drug production, from target identification to marketing approval, takes over 12 years
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
[PDF][PDF] Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions
A Dhakal, C McKay, JJ Tanner, J Cheng - 2021 - pdfs.semanticscholar.org
New drug production, from target identification to marketing approval, takes over 12 years
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
Artificial intelligence in the prediction of protein-ligand interactions: recent advances and future directions.
A Dhakal, C McKay, JJ Tanner… - Briefings in Bioinformatics, 2022 - europepmc.org
New drug production, from target identification to marketing approval, takes over 12 years
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions
A Dhakal, C McKay, JJ Tanner, J Cheng - Briefings in Bioinformatics, 2021 - osti.gov
New drug production, from target identification to marketing approval, takes over 12 years
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
[PDF][PDF] Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions
A Dhakal, C McKay, JJ Tanner, J Cheng - 2021 - researchgate.net
New drug production, from target identification to marketing approval, takes over 12 years
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
[PDF][PDF] Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions
A Dhakal, C McKay, JJ Tanner… - Briefings in …, 2022 - academic.oup.com
New drug production, from target identification to marketing approval, takes over 12 years
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions.
A Dhakal, C McKay, JJ Tanner… - Briefings in …, 2022 - search.ebscohost.com
New drug production, from target identification to marketing approval, takes over 12 years
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
Artificial intelligence in the prediction of protein-ligand interactions: recent advances and future directions
A Dhakal, C McKay, JJ Tanner… - Briefings in …, 2022 - pubmed.ncbi.nlm.nih.gov
New drug production, from target identification to marketing approval, takes over 12 years
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
[HTML][HTML] Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions
A Dhakal, C McKay, JJ Tanner… - Briefings in …, 2022 - ncbi.nlm.nih.gov
New drug production, from target identification to marketing approval, takes over 12 years
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions
A Dhakal, C McKay, JJ Tanner, J Cheng - Briefings in Bioinformatics, 2022 - par.nsf.gov
New drug production, from target identification to marketing approval, takes over 12 years
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …
and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the …